ANHL12P1 A Randomized Phase II Trial of Brentuximab Vedotin (SGN35, NSC# 749710) or Crizotinib (NSC# 749005, commercially labeled) in Combination with Chemotherapy for Newly Diagnosed Patients with Anaplastic Large Cell Lymphoma (ALCL) IND#117117

This Study is
No Longer Enrolling

Details
Age

Child

Type of Study

Treatment

Scope

National

Locations

Childrens Hospital Colorado

Study ID

Protocol Number: 15-1921

More information available at ClinicalTrials.gov: NCT01979536

Categories

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers